US$ 29.09
glp-1 for binge eating disorder Experts express alarm that RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? And how can clinicians protect patients from risk? #504: Adult Eating Disorders in
Description
The UK medicines regulator, the MHRA, has updated the product information for healthcare professionals and patients regarding the "small risk of severe acute pancreatitis in patients taking GLP-1s." While rare, the sheer scale of GLP-1 use in the UK with one recent study suggesting 1.6 million adults had used them in the last 12 months, and 3.3 million were interested in trying them in the following year makes it important for clinicians and patients to be aware of the warning signs of pancreatitis, said the regulator

Conclusion As clinical trials expand, these medications could redefine how we approach both metabolic and mental health
NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site

Erbil D, Eren CY, Demirel C, Kucuker MU, Solaroglu I, Eser HY

Adjustments to other diabetes medications may be necessary to maintain glycemic control

[DOI] [PMC free article] [PubMed] [Google Scholar] 100.Miller L.E., Ouwehand A.C., Ibarra A
